Neuropathy

Breakthrough Hope for Cannabis-Induced Psychosis: Groundbreaking Treatment Option Unveiled

The novel study conducted by the Princess Mother National Institute on Drug Abuse Treatment (PMNIDAT) in Thailand has led to promising advances in understanding the efficacy of pharmacological treatments for cannabis-induced psychosis (CIP). With cannabis use becoming increasingly prevalent worldwide, the revelation of these findings offers renewed hope for effective Read more…

By Yana Djonua, ago

Unlocking the Gut-Brain Link: Schizophrenia’s Hidden Connection Revealed!

Unlocking the Gut-Brain Link: Schizophrenia’s Hidden Connection Revealed! The intricate connection between the gut microbiome and brain health has garnered increasing attention in recent years. This breakthrough study dives deep into the microbiome’s influence on schizophrenia, a complex psychiatric disorder. By meticulously analyzing how the gut and brain communicate, particularly Read more…

By Yana Djonua, ago

Unveiling Cannabis & Psychosis: The 5-Year Study That Could Change Everything!

🌿🧠 Unveiling Cannabis & Psychosis: The 5-Year Study That Could Change Everything! 🚦✨ The connection between cannabis use and psychosis has been a subject of ongoing research. Understanding its longer-term impacts on health and social functioning is crucial. A recent five-year longitudinal study sheds light on this complex relationship, with Read more…

By Yana Djonua, ago

Discover How CBD is Revolutionizing Psychosis Prevention: New Study Reveals Promising Results!

Discover How CBD is Revolutionizing Psychosis Prevention: New Study Reveals Promising Results! In a groundbreaking study, researchers have discovered exciting new evidence on the impact of Cannabidiol (CBD) in preventing psychosis. As a non-intoxicating component of cannabis, CBD shows anxiolytic and antipsychotic properties, alongside a strong safety profile, making it Read more…

By Yana Djonua, ago
antipsychotic

Endocannabinoid Degradation Enzyme Inhibitors as Potential Antipsychotics: A Medicinal Chemistry Perspective

This comprehensive study, available on PubMed Central, examines the potential of targeting endocannabinoid degradation enzyme inhibitors for the development of new antipsychotic medications. Schizophrenia and other psychotic disorders often lack effective treatments with minimal side effects, driving the need for innovative approaches. The endocannabinoid system, known for its role in Read more…

By Yana Djonua, ago
antipsychotics

Endocannabinoid Degradation Enzyme Inhibitors as Potential Antipsychotics: A Medicinal Chemistry Perspective

Schizophrenia and related psychotic disorders pose significant challenges in contemporary psychiatry, necessitating the exploration of novel therapeutic approaches. Recent research has turned towards the endocannabinoid system and its role in psychiatric disorders. Notably, endocannabinoid degradation enzyme inhibitors have emerged as potential antipsychotics, promising a new frontier in medicinal chemistry. The Read more…

By Yana Djonua, ago
Anandamide

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia

Cannabidiol (CBD), a non-psychoactive compound found in cannabis, has garnered significant attention due to its potential therapeutic effects across a variety of conditions. One of the critical pathways through which CBD exerts these effects is by enhancing anandamide signaling within the endocannabinoid system (ECS). The ECS is a complex cell-signaling Read more…

By Yana Djonua, ago

Does CBD oil help neuropathy?

Every individual on the planet has a central nervous system (CNS). The central nervous system consists of the brain and spinal cord. It is called the central nervous system because, much like a powerful computer, it functions as a central processing unit, gathering important information from all over the body. Read more…

By Yana Djonua, ago